Genome-Wide Assessment for Genetic Variants Associated with Ventricular Dysfunction after Primary Coronary Artery Bypass Graft Surgery

Background Postoperative ventricular dysfunction (VnD) occurs in 9–20% of coronary artery bypass graft (CABG) surgical patients and is associated with increased postoperative morbidity and mortality. Understanding genetic causes of postoperative VnD should enhance patient risk stratification and improve treatment and prevention strategies. We aimed to determine if genetic variants associate with occurrence of in-hospital VnD after CABG surgery. Methods A genome-wide association study identified single nucleotide polymorphisms (SNPs) associated with postoperative VnD in male subjects of European ancestry undergoing isolated primary CABG surgery with cardiopulmonary bypass. VnD was defined as the need for ≥2 inotropes or mechanical ventricular support after CABG surgery. Validated SNPs were assessed further in two replication CABG cohorts and meta-analysis was performed. Results Over 100 SNPs were associated with VnD (P<10−4), with one SNP (rs17691914) encoded at 3p22.3 reaching genome-wide significance (Padditive model = 2.14×10−8). Meta-analysis of validation and replication study data for 17 SNPs identified three SNPs associated with increased risk for developing postoperative VnD after adjusting for clinical risk factors. These SNPs are located at 3p22.3 (rs17691914, ORadditive model = 2.01, P = 0.0002), 3p14.2 (rs17061085, ORadditive model = 1.70, P = 0.0001) and 11q23.2 (rs12279572, ORrecessive model = 2.19, P = 0.001). Conclusions No SNPs were consistently associated with strong risk (ORadditive model>2.1) of developing in-hospital VnD after CABG surgery. However, three genetic loci identified by meta-analysis were more modestly associated with development of postoperative VnD. Studies of larger cohorts to assess these loci as well as to define other genetic mechanisms and related biology that link genetic variants to postoperative ventricular dysfunction are warranted.

[1]  A. Hofman,et al.  Genomic Variation Associated With Mortality Among Adults of European and African Ancestry With Heart Failure: The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium , 2010, Circulation. Cardiovascular genetics.

[2]  N. Khaper,et al.  Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. , 2010, Antioxidants & redox signaling.

[3]  T. David,et al.  Predictors of low cardiac output syndrome after coronary artery bypass. , 1996, The Journal of thoracic and cardiovascular surgery.

[4]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[5]  Michael J Ackerman,et al.  SCN4B-Encoded Sodium Channel &bgr;4 Subunit in Congenital Long-QT Syndrome , 2007, Circulation.

[6]  J. Seidman,et al.  Natriuretic Peptide System Gene Variants Are Associated with Ventricular Dysfunction after Coronary Artery Bypass Grafting , 2009, Anesthesiology.

[7]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[8]  G. Baron,et al.  Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality* , 2006, Critical care medicine.

[9]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[10]  P. Deloukas,et al.  Large Scale Association Analysis of Novel Genetic Loci for Coronary Artery Disease , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[11]  C. Croce,et al.  Fragile gene product, Fhit, in oxidative and replicative stress responses , 2009, Cancer science.

[12]  Chun Li,et al.  Evaluation of coverage variation of SNP chips for genome-wide association studies , 2008, European Journal of Human Genetics.

[13]  R. Kazanegra,et al.  Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. , 2004, Journal of the American College of Cardiology.

[14]  P. Ponikowski,et al.  Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II , 2008, European journal of heart failure.

[15]  Alberto Piazza,et al.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants , 2009, Nature Genetics.

[16]  E. Cook,et al.  Comparison of the Utility of Preoperative versus Postoperative B-type Natriuretic Peptide for Predicting Hospital Length of Stay and Mortality after Primary Coronary Artery Bypass Grafting , 2010, Anesthesiology.

[17]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[18]  K P Lee,et al.  TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial–mesenchymal transition , 2008, Oncogene.

[19]  K. Mossman The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[20]  S. Aranki,et al.  Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting. , 2008, The Journal of thoracic and cardiovascular surgery.

[21]  Jonathan Seidman,et al.  Genetic causes of human heart failure. , 2005, The Journal of clinical investigation.

[22]  U. Ikeda,et al.  Cardiac function-related gene expression profiles in human atrial myocytes. , 2004, Biochemical and biophysical research communications.

[23]  D. Roden,et al.  Mutations in Sodium Channel β1- and β2-Subunits Associated With Atrial Fibrillation , 2009, Circulation. Arrhythmia and electrophysiology.

[24]  S. Crosby,et al.  Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. , 2008, Physiological genomics.